Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 4
2014 15
2015 21
2016 24
2017 23
2018 35
2019 41
2020 31
2021 24
2022 32
2023 31
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

260 results

Results by year

Filters applied: . Clear all
Page 1
Performance of cone-beam computed tomography (CBCT) in comparison to conventional computed tomography (CT) and magnetic resonance imaging (MRI) for the detection of bone invasion in oral squamous cell cancer (OSCC): a prospective study.
Straub A, Linz C, Lapa C, Hartmann S, Kübler AC, Müller-Richter UDA, Faber J, Bley T, Brumberg J, Kertels O, Brands RC. Straub A, et al. Among authors: lapa c. BMC Oral Health. 2024 Mar 16;24(1):341. doi: 10.1186/s12903-024-04057-4. BMC Oral Health. 2024. PMID: 38493083 Free PMC article. Clinical Trial.
SSTR Antagonists as Theranostic Option in Merkel Cell Carcinoma.
Kircher M, Amerein A, Augustin M, Reitsam NG, Enke JS, Patt M, Wienand G, Bundschuh RA, Pfob CH, Lapa C, Dierks A. Kircher M, et al. Among authors: lapa c. J Nucl Med. 2024 Feb 8:jnumed.123.267124. doi: 10.2967/jnumed.123.267124. Online ahead of print. J Nucl Med. 2024. PMID: 38331456 No abstract available.
SARIFA as a new histopathological biomarker is associated with adverse clinicopathological characteristics, tumor-promoting fatty-acid metabolism, and might predict a metastatic pattern in pT3a prostate cancer.
Enke JS, Groß M, Grosser B, Sipos E, Steinestel J, Löhr P, Waidhauser J, Lapa C, Märkl B, Reitsam NG. Enke JS, et al. Among authors: lapa c. BMC Cancer. 2024 Jan 12;24(1):65. doi: 10.1186/s12885-023-11771-9. BMC Cancer. 2024. PMID: 38216952 Free PMC article.
CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges.
Werner R, Haug A, Buske C, Heidegger S, Illert AL, Bassermann F, Herhaus P, Buck A, Duell J, Topp MS, Kraus S, Einsele H, Lapa C, Raderer M, Lenz G, Habringer S, von Tresckow B, Keller U. Werner R, et al. Among authors: lapa c. Nuklearmedizin. 2024 Apr;63(2):57-61. doi: 10.1055/a-2194-9965. Epub 2024 Jan 8. Nuklearmedizin. 2024. PMID: 38190998 Free PMC article.
CXCR4-directed PET/CT with [68 Ga]Ga-pentixafor in solid tumors-a comprehensive analysis of imaging findings and comparison with histopathology.
Dreher N, Hahner S, Fuß CT, Schlötelburg W, Hartrampf PE, Serfling SE, Schirbel A, Samnick S, Higuchi T, Weich A, Lapa C, Rosenwald A, Buck AK, Kircher S, Werner RA. Dreher N, et al. Among authors: lapa c. Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1383-1394. doi: 10.1007/s00259-023-06547-z. Epub 2023 Dec 12. Eur J Nucl Med Mol Imaging. 2024. PMID: 38082196 Free PMC article.
Intense PSMA expression of the uvula detected by [68 Ga]Ga-PSMA-PET/CT.
Glantschnig L, Dierks A, Wienand G, Pfob CH, Bundschuh RA, Lapa C, Kircher M. Glantschnig L, et al. Among authors: lapa c. Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1488-1489. doi: 10.1007/s00259-023-06511-x. Epub 2023 Nov 13. Eur J Nucl Med Mol Imaging. 2024. PMID: 37953392 Free PMC article. No abstract available.
260 results